ClinicalTrials.gg
Sign In
RecruitingNCT06616753StatutvaxPatUpdated Jun 6, 2025

Evaluation of Patients' Knowledge of Their Vaccination Status and Their Relationship to Vaccination at Melun Hospital

An observational study in Vaccinia, sponsored by Groupe Hospitalier Sud Ile-de-France. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-06.

Sponsored by Groupe Hospitalier Sud Ile-de-France · Observational

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year 1 month ago, but the record still lists the study as recruiting.
  • Started Jul 2024; still recruiting 2 years 3 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
140
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this observational study is to learn about the rate of knowledge of own vaccination status among patients hospitalized at Melun hospital. The main questions it aims to answer are:

  • the rate of knowledge of its vaccination status among patients hospitalized at Melun hospital
  • hospitalized patients' attitude to vaccination in general. Evaluate the number of patients wishing to update their vaccination status. Observe the influence of various factors (gender, occupation, presence or absence of GP, chronic illness) on vaccination status in Melun, France Participants will be asked to complete a questionnaire during hospitalization.
Read the detailed description

As part of the national "European Vaccination Week" event organized by the French Ministry of Health and Prevention, we are asking a sample of patients hospitalized in our hospital to complete a questionnaire on their knowledge of their vaccination status, and to assess their relationship with vaccination.

Questionnaire administered to patient during hospitalization (n=140 patients). Patients randomly selected by the Department of Medical Information of the hospital at the beginning of the survey week.

Patients randomly selected from each of the 10 departments of the CH of Melun (internal medicine, infectious diseases, gastroenterology, pneumology, surgery, BCR medicine, cardiology, nephrology, follow-up care and rehabilitation and geriatrics) and accompanied to complete a questionnaire set up by the Public Health Unit (USP) and Hygiene Operational Team (EOH) of the CH of Melun.

02

Conditions studied

  • Vaccinia

Browse trials for

03

In context

Vaccinia

54 studies on the registry are indexed under Vaccinia; 6 are open to participants now.

Browse Vaccinia studies →

Lead sponsor

Groupe Hospitalier Sud Ile-de-France is the lead sponsor of 4 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients hospitalized at CH Melun

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • French-speaking and non-demented patient : able to speak and understand French and without dementia
  • Adult patient (Age ≥ 18 years)
  • Main place of residence in France
  • Hospitalized in a department of the CH of Melun

Exclusion criteria

Exclusion Criteria :

  • Does not speak French or dementia
  • Patient's refusal to participate in the study
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
140 participants (estimated)
Patient registry
No

Interventions

  • Biologicalvaccination status

    knowledge of own vaccination status

06

What researchers measure

Primary outcomes

  1. Evaluate the rate of knowledge of own vaccination status

    Time frame: Day 1

Secondary outcomes

  1. Evaluate the number of patients wishing to update their vaccination status

    Time frame: Day 1

  2. 3.Observe the influence of various factors in vaccination status at Melun Hospital : 3.1 % of each gender 3.2 % of patients with a specefic occupation 3.3 % of patients with or without a treating physician 3.4 Rate of patients with chronic illness

    Time frame: Day 1

07

Study locations

1 of 1 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2024 (actual). Primary completion is estimated for Oct 2025, 15 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 15, 2023
First posted
Sep 27, 2024
StartActual
Jul 16, 2024
Primary completionEst.
Oct 2025
CompletionEst.
Dec 2025
Last update
Jun 6, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06616753
Lead sponsor
Groupe Hospitalier Sud Ile-de-France
Responsible party
Sponsor
First posted
Sep 27, 2024
Start date
Jul 16, 2024
Primary completion
Oct 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Jun 6, 2025

Study contacts

CORALIE NOEL
Contact
coralie.noel@ghsif.fr
0033181742127
AGHER AREZKI
Contact
arezki.agher@ghsif.fr
0033181742228
CORALIE NOEL
principal investigator · Groupe Hospitalier Sud Ile-de-France

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Vaccinia →

Other studies from this sponsor

Groupe Hospitalier Sud Ile-de-France

Start the discussion